A detailed history of Encompass More Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Encompass More Asset Management holds 2,123 shares of JNJ stock, worth $407,361. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,123
Previous 1,765 20.28%
Holding current value
$407,361
Previous $269,000 46.1%
% of portfolio
0.1%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$155.17 - $185.42 $55,550 - $66,380
358 Added 20.28%
2,123 $393,000
Q2 2025

Aug 07, 2025

SELL
$146.36 - $159.82 $52,396 - $57,215
-358 Reduced 16.86%
1,765 $269,000
Q1 2025

May 09, 2025

SELL
$142.06 - $167.7 $4,687 - $5,534
-33 Reduced 1.53%
2,123 $352 Million
Q4 2024

Jan 21, 2025

SELL
$143.34 - $165.86 $43,002 - $49,758
-300 Reduced 12.21%
2,156 $312 Million
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $357,298 - $411,085
2,456 New
2,456 $398 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $502B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Encompass More Asset Management Portfolio

Follow Encompass More Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Encompass More Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Encompass More Asset Management with notifications on news.